Dr. Clokie is a practicing, oral surgeon that also specializes in performing maxillofacial surgery. When he is not working in the field of oral surgery, he also prides himself in being a dedicated, admirable scientist and a diligent, innovative entrepreneur.
He holds the title of CEO for the Induce Biologics Inc, which is known as an institution that is dedicated to developing medications designed to cure or solve problems with musculoskeletal reconstruction. This industry has been assisting an extensive group of patients in need of such treatments.
For over 30 years, Dr. Clokie practiced clinical dentistry and also taught it in an academic setting. He was given the honorable title of “Head of Oral and Maxillofacial Surgery” while he was still a professor. He received this award in 1998 during his academic career at the University of Toronto where he taught and shared his expertise in Maxillofacial and oral surgery techniques.
Just this year, in 2017, he decided to retire from the world of academics after teaching students for almost two decades. Not only has he spread his wings as a professor, but Dr. Clokie has also been on many scientific advisory boards for large scale corporations.
Dr. Cameron Clokie has traveled across the globe, publishing and presenting numerous amounts of information regarding the reconstruction of bones and the necessary medication required for regeneration.
Crunchbase revealed that Cameron Clokie has made an effort to utilize his vast sea of information in assisting other commercial and academic interest in attaining a higher level of knowledge and intelligence regarding practicing in these medical fields.
Dr. Clokie holds 25 separate patents, all largely related to his field of expertise, both existing and pending. These patents have given him an advantage in helping develop relationships with a multitude of corporate interest.
His business knowledge allows him to interact with a diverse range of clients who hold specific interest in areas he has been studying and teaching for decades. His patents are related primarily to bone reconstruction, a budding industry with a significant amount of capital available to be made.